Tetrandrine Ameliorates Ischaemia-reperfusion Injury of Rat Myocardium Through Inhibition of Neutrophil Priming and Activation
Overview
Affiliations
1. We have previously shown that tetrandrine (TTD), a bisbenzyltetrahydroiosquinoline isolated from the Chinese herb Stephania tetrandra, inhibits neutrophil adhesion, Mac-1 expression, and reactive oxygen species (ROS) production. To examine whether inhibition of neutrophil function may confer upon TTD the ability to prevent myocardial ischaemia-reperfusion (MI/R) injury, experiments were performed on rats subjected to coronary ligation followed by reperfusion for induction of MI/R injury. 2. Intravenous administration of TTD (0.1 and 1.0 mg kg-1) 15 min prior to coronary ligation completely prevented MI/R-associated mortality. TTD pretreatment also significantly reduced MI/R-induced ventricular tachyarrhythmia, myocardial infarct size, and neutrophil infiltration. 3. However, TTD pretreatment did not influence mean arterial blood pressure, heart rate, or product of pressure-rate, indicating that TTD extenuated MI/R through mechanisms independent of modulating haemodynamics or myocardial oxygen demand. 4. Peripheral blood neutrophils were isolated for ex vivo examination of shape change and Mac-1 upregulation of neutrophils, two sensitive indicators of proinflammatory priming, as well as N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced adhesion and ROS production, parameters commonly used for the assessment of neutrophil activation. 5. Neutrophils from MI/R animals showed significant shape change and Mac-1 upregulation, both of which were prevented by TTD-pretreatments. On the other hand, fMLP-induced adhesion and ROS production of neutrophils were markedly enhanced by MI/R but diminished in TTD-pretreated animals. 6. These data suggest that the protective effect of TTD against MI/R injury can be accounted for by inhibition of neutrophil priming and activation, thereby abolishing subsequent infiltration and ROS production that cause MI/R injury.
Insights on exploring the therapeutic potential and structural modification of Tetrandrine.
Gong L, Liu H, Xu B, Yu T, Wang Y, Niu S Future Med Chem. 2024; 16(24):2687-2700.
PMID: 39606807 PMC: 11731063. DOI: 10.1080/17568919.2024.2432297.
Wang Y, Shou X, Wu Y, Li D Front Immunol. 2024; 15:1411301.
PMID: 39050842 PMC: 11266024. DOI: 10.3389/fimmu.2024.1411301.
Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated.
Li T, Yan Z, Fan Y, Fan X, Li A, Qi Z Front Cardiovasc Med. 2023; 9:1077290.
PMID: 36698953 PMC: 9868426. DOI: 10.3389/fcvm.2022.1077290.
Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase.
Wang Y, Cai X, Wu Z, Tang L, Lu L, Xu Y Mol Med Rep. 2021; 23(4).
PMID: 33649825 PMC: 7930946. DOI: 10.3892/mmr.2021.11936.
Jiang Y, Liu M, Liu H, Liu S Phytochem Rev. 2020; 19(2):449-489.
PMID: 32336965 PMC: 7180683. DOI: 10.1007/s11101-020-09673-w.